Mutations in NPC1, a protein located at the late endosomal/lysosomal limiting membrane, account for approximately 95% of NPC cases, while mutations in NPC2, a soluble cholesterol-binding protein found in the lysosomal lumen, are responsible for the remaining 5%. This evidence concerns the gene NPC2 and nasopharyngeal carcinoma.